Cell Therapeutics Appoints New Chief Medical OfficerSacramento Bee… CTI's ongoing randomized controlled phase 3 clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have relapsed after one …and more &ra…
InGen BioSciences Group, Exclusive Distributor for Cylex …PR Newswire (press release)Cainelli F., Vento S. Infections and solid organ transplant rejection: a … Using an immune functional assay to differentiate acute cellular rejection from recurren…
CHILLY-MAZARIN, France, June 14, 2012 /PRNewswire/ –InGen BioSciences, specialised in the development and commercialisation of mono and multiparametric in vitro diagnostic tests announced a new exclusive …
Seattle Genetics announced updated survival data from a pivotal clinical trial of single-agent ADCETRIS in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant showing …
Seattle Genetics, Inc. today announced updated survival data from a pivotal clinical trial of single-agent ADCETRIS in patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplant showing that the median overall survival …
生物谷 (新闻发布)Nature：AMPK酶在癌症中的双重作用生物谷 (新闻发布)趋化因子及受体CCL5/CCR5促进乳腺癌转移 · Cancer Res：蛋白质RAL与肿瘤的侵袭性特征有关 · J Biol Chem：方靖等揭示FOX…
Scientists grow new vein from girl's stem cellBusiness StandardFor the first time, scientists led by an Indian-origin researcher have successfully replaced a major blood vessel in a 10-year-old girl with a vein grown in a lab using her own stem cel…
As two Sullivan County men went through a life-saving kidney transplant on Wednesday, a worldwide audience checked in online to follow the progress of the surgery and ask questions of the medical team via Indiana’s first “Twittercast” of a live s…
Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced updated survival data from a pivotal Phase II clinical trial of single-agent brentuximab vedotin in patients with relapsed or r…
Seven years ago, Justine Laymond lay on a hospital bed on life-support. After a double lung transplant, the 39-year-old British woman is a crew member on Edinburgh Inspiring Capital, the Scottish entrant in the Clipper Round the World Yacht Race. (CHRI…